TP53 and small cell lung carcinoma: Mutations in this gene are associated with cancers of the adrenal gland, bladder, breast, brain, head and neck (H&N), liver, small cell lung cancer (SCLC), colorectal, bone, muscle, and ovary, which makes p53 an ideal antigen for cancer vaccine design [89].